journal article·2025-04Open access

Generation of Site‐Specifically Labeled Affinity Reagents via Use of a Self‐Labeling Single Domain Antibody

Stanley Fayn, Swarnali Roy, Chino C. Cabalteja, Woonghee Lee, Hima Makala, Kwamena Baidoo, Divya Nambiar, Julia Sheehan‐Klenk, Joon‐Yong Chung, Jesse Buffington, Mitchell Ho, Freddy E. Escorcia, Ross W. Cheloha

Advanced Science· Volume 12· Issue 14

Abstract

Abstract Several chemical and enzymatic methods have been used to link antibodies to moieties that facilitate visualization of cognate targets. Emerging evidence suggests that the extent of labeling, dictated by the type of chemistry used, has a substantial impact on performance, especially in the context of antibodies used for the visualization of tumors in vivo. These effects are particularly pronounced in studies using small antibody fragments, such as single‐domain antibodies, or nanobodies. Here, we leverage a new variety of conjugation chemistry, based on a nanobody that forms a crosslink with a specialized high‐affinity epitope analogue, to label target‐specific nanobody constructs with functionalities of choice, including fluorophores, chelators, and click chemistry handles. Using heterodimeric nanobody conjugates, comprised of an antigen recognition module and a self‐labeling module, enables us to attach the desired functional group at a location distal to the site of antigen recognition. Constructs generated using this approach bound to antigens expressed on xenograft murine models of liver cancer and allowed for non‐invasive diagnostic imaging. The modularity of our approach using a self‐labeling nanobody offers a novel method for site‐specific functionalization of biomolecules and can be extended to other applications for which covalent labeling is required.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Glycosylation and Glycoproteins Research · Biochemical and Structural Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Molecular Imaging Branch Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD 20892 USA

Oxford Institute for Radiation Oncology Department of Oncology University of Oxford Oxford OX3 7DQ UK

Chemical Biology in Signaling Section National Institutes of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda MD 20892 USA

Antibody Engineering Program Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD 20892 USA

Laboratory of Molecular Biology Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD 20892 USA

Radiation Oncology Branch Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD 20892 USA

Funding

NIH Office of the Director · National Institute of Diabetes and Digestive and Kidney Diseases · National Cancer Institute

References (53)

Show source-provided references
1. 10.1074/jbc.REV120.01296010.1074/jbc.REV120.012960 ↗
2. 10.7150/thno.3744310.7150/thno.37443 ↗
3. 10.1186/s13550-018-0374-810.1186/s13550-018-0374-8 ↗
4. 10.1016/S1470-2045(24)00249-310.1016/S1470-2045(24)00249-3 ↗
5. 10.1039/D1CB00023C10.1039/D1CB00023C ↗
6. 10.1021/acs.chemrev.9b0073810.1021/acs.chemrev.9b00738 ↗
7. 10.1016/S1470-2045(24)00402-910.1016/S1470-2045(24)00402-9 ↗
8. 10.1007/s11307-015-0919-410.1007/s11307-015-0919-4 ↗
9. 10.3390/antib801001210.3390/antib8010012 ↗
10. 10.2967/jnumed.122.26517110.2967/jnumed.122.265171 ↗
11. 10.1007/s11307-015-0920-y10.1007/s11307-015-0920-y ↗
12. 10.1146/annurev-cellbio-100617-06252710.1146/annurev-cellbio-100617-062527 ↗
13. Rehm F. B. H. · J. Chem. Biol. · 2021 · 22 · 2079
14. 10.1021/acs.bioconjchem.4c0026410.1021/acs.bioconjchem.4c00264 ↗
15. 10.1021/bc400122c10.1021/bc400122c ↗
16. 10.1021/acs.bioconjchem.2c0033410.1021/acs.bioconjchem.2c00334 ↗
17. 10.3390/molecules2601000410.3390/molecules26010004 ↗
18. 10.2967/jnumed.121.26256210.2967/jnumed.121.262562 ↗
19. 10.1083/jcb.20170911510.1083/jcb.201709115 ↗
20. 10.1073/pnas.121425511010.1073/pnas.1214255110 ↗
21. 10.1016/j.molimm.2019.08.00810.1016/j.molimm.2019.08.008 ↗
22. 10.1021/acschembio.2c0040710.1021/acschembio.2c00407 ↗
23. 10.1021/acs.biochem.1c0025810.1021/acs.biochem.1c00258 ↗
24. 10.1021/acschembio.9b0049310.1021/acschembio.9b00493 ↗
25. 10.1038/ncomms753610.1038/ncomms7536 ↗
26. 10.1002/hep.184006011210.1002/hep.1840060112 ↗
27. 10.1089/cbr.2009.067410.1089/cbr.2009.0674 ↗
28. 10.1021/acs.bioconjchem.9b0063910.1021/acs.bioconjchem.9b00639 ↗
29. 10.1021/jacs.9b0916610.1021/jacs.9b09166 ↗
30. 10.1021/acs.bioconjchem.8b0056310.1021/acs.bioconjchem.8b00563 ↗
31. 10.1002/anie.20241762010.1002/anie.202417620 ↗
32. 10.3389/fimmu.2021.83808210.3389/fimmu.2021.838082 ↗
33. 10.1016/j.smim.2020.10142510.1016/j.smim.2020.101425 ↗
34. 10.1021/jacs.2c0759410.1021/jacs.2c07594 ↗
35. 10.1021/cb800025k10.1021/cb800025k ↗
36. 10.1038/nbt76510.1038/nbt765 ↗
37. 10.1073/pnas.111548510910.1073/pnas.1115485109 ↗
38. Alam M. K. · J. Chem. Biol. · 2017 · 18 · 2217
39. 10.1016/j.chembiol.2021.01.01110.1016/j.chembiol.2021.01.011 ↗
40. 10.1038/srep3929110.1038/srep39291 ↗
41. 10.1007/s11307-018-1222-y10.1007/s11307-018-1222-y ↗
42. 10.1038/srep0726610.1038/srep07266 ↗
43. 10.1021/acs.molpharmaceut.7b0017210.1021/acs.molpharmaceut.7b00172 ↗
44. 10.1021/acsomega.1c0585610.1021/acsomega.1c05856 ↗
45. 10.1038/nmeth.320710.1038/nmeth.3207 ↗
46. Sang Z. · Struct. Lond. Engl. · 2022 · 30 · 418
47. 10.1038/s41467-024-49068-510.1038/s41467-024-49068-5 ↗
48. 10.1002/pro.486610.1002/pro.4866 ↗
49. 10.1124/molpharm.123.00079710.1124/molpharm.123.000797 ↗
50. SEER*Explorer: An Interactive Website for SEER Cancer Statistics [Internet]. Surveillance Research Program National Cancer Institute https://Seer.Cancer.Gov/Statistics‐Network/Explorer/(Accessed: November2024).
51. 10.1002/hep.3094910.1002/hep.30949 ↗
52. 10.1021/acs.bioconjchem.6b0023510.1021/acs.bioconjchem.6b00235 ↗
53. 10.3390/ijms2119722210.3390/ijms21197222 ↗